Tag Archive for: NutraHemp CBD

NutraLife Biosciences Encouraged By CVS Health Corporation’s Decision to Distribute CBD at 800 Stores in the U.S.

/in

Summary: CVS Health Corp. announces it will carry cannabidiol, also known as CBD, the non-psychoactive derivative of hemp in about 800 stores across the US.

NutraLife Biosciences, Inc. (“the Company” or “NutraLife”) (OTCQB: NLBS) notes current trends in the retail space including CVS Health Corp.’s announcement that it will carry products containing CBD derived from hemp in about 800 of its U.S. drugstores.

NutraLife announces new additions to its NutraHempCBD product line with a micro shot CBD twists in 5 of its signature formulations including; sleep, pain, stress, weight, and sleep. The NutraHempCBD twists are designed for on-the-go convenience and set to launch on April 15 of this year.

“It is encouraging to see that mainstream retail giants like CVS are offering hemp derived CBD products to consumers,” said Edgar Ward, Founder and Chief Executive Officer of NutraLife Biosciences.

NutraHempCBD is in the last stages of development of its CBD micro shot twist products offering a single serving of CBD plus other clinically tested ingredients for daily health and wellness applications. The launch of the CBD micro shot twists in its 5 signature formulations demonstrate evolving and innovative retail-ready nutraceutical and industrial hemp CBD products.

Since 2013, the Company has engaged in the manufacturing and distribution of nutraceutical products for both branded and private label sales. In 2017, the Company launched its industrial hemp CBD products for private label sales and its own NutraHempCBD brand. The Company’s products are sold at a variety of retailers including drugstores.

According to reports, executives on Curaleaf’s earnings conference call said CVS would begin to carry its Curaleaf hemp lotions and transdermal patches in about 800 stores across 10 U.S. states. Chief Executive Officer of CVS, Joe Lusardi said Wednesday that the products would be available in stores by this Friday and through the CVS website “soon.”

On December 20, 2018, the U.S. Food and Drug Administration completed an evaluation of three generally recognized as safe (GRAS) notices for hemp seed-derived food ingredients. The agency concluded that hulled hemp seed (GRN765), hemp seed protein powder (GRN771), and hemp seed oil (GRN778) are GRAS as they contain only trace amounts of THC and CBD. The GRAS notices are for three different hemp seed-derived ingredients for certain uses including adding them as a source of protein, carbohydrates, oil, and other nutrients to beverages (juices, smoothies, protein drinks, plant-based alternatives to dairy products), soups, dips, spreads, sauces, dressings, plant-based alternatives to meat products, desserts, baked goods, cereals, snacks and nutrition bars. The FDA’s complete release of the GRAS notice can be read here.

NutraLife BioSciences is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). NLBS recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NLBS’s filings with the SEC can be viewed at www.sec.gov. NLBS’s CBD products and information about the Company’s direct sales program can be found online at https://nutrahempcbd.com and by following the company on Instagram.

* The statements in this Release have not been evaluated by the Food and Drug Administration.

* NutraLife’s CBD and nutraceutical products are not intended to diagnose, treat, cure or prevent any disease.

* NutraLife is not affiliated with and has no association with Curaleaf or CVS Health Corp.

Forward-Looking Statements

This communication from NutraLife BioSciences, Inc. (the “Company”) contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

Contact:

NutraLife Biosciences, Inc.
6601 Lyons Road
Suite L-6 Coconut Creek
FL  33073 Telephone
Telephone: 888-509-8901
www.Nutralifebiosciences.com

NutraLife Biosciences, Inc. (OTCQB: NLBS) Receives Contract to Provide Its Technologies and Delivery System for Pharmaceutical Products by cGMP Pharmacy

/in

NutraLife Biosciences enters into a contract with a cGMP pharmacy to provide its technologies and a delivery system for pharmaceutical products.

NutraLife Biosciences, Inc. (“the Company” or “NutraLife”) (OTCQB: NLBS) announces it has signed an agreement with Orlando Pharmacy, a USP 797 compliant compounding pharmacy, to provide its technologies and an innovative delivery system for pharmaceutical products

Craig Sicinski, a pharmacist and owner of Orlando Pharmacy and a board advisor to BioHealth Technologies, a CBD and nutraceutical AI PAAS (Platform As A Service) company commented, “We are thrilled to have this new agreement with with NutraLife and to use its technologies and delivery system in our pharmaceutical products. Our shared goal is to discover new innovations within the life sciences space.”

Edgar Ward, CEO and Founder of NutraLife Biosciences stated, “this is a great opportunity for us to expand our technologies and delivery systems into the Pharmaceutical marketplace. Pharmacist Craig Sicinski of Orlando Pharmacy is in-line with our mission to develop the most effective and efficient delivery systems. With Orlando Pharmacy, we are taking our first steps into the pharmaceutical marketplace.”

“We are excited to explore the possibilities for our technologies and processes in the life sciences space and to have our technologies and delivery systems used in the creation of compounded pharmaceutical products  by the pharmacists at Orlando Pharmacy, an experienced cGMP facility. We look forward to a long and rewarding relationship with Mr. Sicinski and his team at Orlando Pharmacy”, said Mr. Ward.

Orlando Pharmacy is a USP 797 compliant pharmacy that has been serving the Orlando community for more than 60 years. Orlando Pharmacy is designated as a Good Neighbor Pharmacy, a network of more than 4,5000 independent pharmacies.  Orlando Pharmacy prides themselves on their reputation for credibility, integrity, and always going the extra mile to meet the needs of its customers and patients.”

Nutralife Biosciences, Inc. operates a multifaceted life sciences company. Since 2013, NutraLife’s manufacturing facility has been registered with the FDA and operated in accordance with the GMP standard. The Company manufactures and distributes private label and branded nutraceutical and wellness products. Through its subsidiaries, Precision Analytic Testing, Inc., and PhytoChem Technologies, Inc., the Company provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction and processing. In February of 2019, the Company’s subsidiary, NutraDerma Technologies, Inc. acquired its first product, a patented all natural dermal patch designed to ward off insects including mosquitoes.

NutraLife Sciences is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). NLBS recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NLBS’s filings with the SEC can be viewed at www.sec.gov. NLBS’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

* These statements have not been evaluated by the Food and Drug Administration.

* This product is not intended to diagnose, treat, cure or prevent any disease.

Forward-Looking Statements

This communication from NutraLife BioSciences, Inc. (the “Company”) contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

 

Contact:

 

NutraLife Biosciences, Inc.

6601 Lyons Road

Suite L-6 Coconut Creek

FL  33073 Telephone

Telephone: 888-509-8901

www.Nutralifebiosciences.com

St. Patrick’s Day

/in

To read this press release on OTCMarkets.com visit:

NutraHempCBD Announces March Promo Is For You, And Your Pet Too!

 

NutraHempCBD celebrates St. Patrick’s Day with 40% off a 600 mg Full Spectrum Tincture and a Pet Wellness Tincture combo!

NutraHempCBD, a line of hemp-derived cannabidiol (CBD) products from the life sciences company, Nutralife Biosciences, Inc. (Nutralife or “the Company”) is celebrating St. Patrick’s Day by offering 40% off when you buy a 600mg Full Spectrum Tincture and a Pet Wellness Tincture! The promo price will be $80, that’s reduced from the original $135 sticker price.

NutraHempCBD full spectrum cannabidiol formula has 600 mg of hemp-derived CBD in every bottle and has been hailed by consumers as a convenient way to reap the benefits of full-spectrum cannabidiol. This NutraHempCBD formula comes in an easy-to-dose spray instead of an oily dropper and customers can expect a delivery of 14 mg of full-spectrum hemp-derived CBD per six-spray serving. The hemp utilized is grown on a USDA Certified Organic farm and the formula is flavored with stevia leaf extract for a superior taste.

The NutraPet Drops are for your furry friends! Our pet CBD products are designed to provide  anti-inflammatory and overall wellness factors. Our pet-friendly formula comes in convenient CBD drops that can be added directly to your pet’s favorite food or treat. The drops deliver 8.33 mg hemp-derived full spectrum CBD per serving and just like our human spray the CBD is from hemp grown on an organic farm.

NutraLife Biosciences, Inc., formerly known as NutraFuels, Inc., (“NutraLife” or the “Company”) also recently announced a name change to NutraLife BioSciences, Inc. and  new stock trading symbol, NLBS. The Company believes that the name, NutraLife BioSciences better reflects its current and planned future operations.

The Company is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). The Company recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

* These statements have not been evaluated by the Food and Drug Administration.

* This product is not intended to diagnose, treat, cure or prevent any disease.

Forward-Looking Statements

This communication contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

Contact: NutraLife Biosciences, Inc.

6601 Lyons Road

Suite L-6 Coconut Creek

FL  33073 Telephone

888-509-8901

www.Nutralifebiosciences.com

NutraFuels, Inc., to Change its Name to NutraLife BioSciences, Inc. and Proposed Symbol to NLBS

/in

To read this press release on OTCMarkets.com visit:

NutraFuels, Inc., to Change its Name to NutraLife BioSciences, Inc. and Proposed Symbol to NLBS

Coconut Creek, FL, March 05, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraFuels, Inc. (the “Company”) is pleased to announce a name change to NutraLife  BioSciences, Inc. and a new stock trading symbol, NLBS.  The Company believes that the name, NutraLife BioSciences better reflects its current and planned future operations. Commencing March 6, 2019, the Company’s common shares will trade with the stock ticker symbol “NLBS”.

The Company is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). The Company recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

* These statements have not been evaluated by the Food and Drug Administration.

* This product is not intended to diagnose, treat, cure or prevent any disease.

Forward-Looking Statements

This communication contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

NutraFuels, Inc. fka NutraLife Biosciences, Inc. Explores New Delivery Systems with Pharmaceutical GMP Manufacturer

/in

To read this press release on OTCMarkets.com visit:

NutraFuels, Inc. fka NutraLife Biosciences, Inc. Explores New Delivery Systems with Pharmaceutical GMP Manufacturer

Coconut Creek, FL, Feb. 28, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraFuels, Inc., fka NutraLife Biosciences, Inc. (“the Company” or “NutraFuels”) (OTCQB: NTFU) plans to explore additional options for delivery systems for its nutraceutical and wellness products and pharmaceutical delivery systems.

“We are excited to be exploring our capabilities in the life sciences space by engaging in the research and development of more formulations and enhanced delivery systems with an experienced cGMP pharmaceutical manufacturer,” said Edgar Ward, CEO and Founder of NutraFuels.

The Company plans to explore these various pharmaceutical formulations and delivery systems while utilizing the valuable experience of a cGMP pharmaceutical manufacturer.

The Company manufactures and distributes private label and its own branded products under its NutraHempCBD and NutraSpray brands. The Company’s product development, testing and research are conducted by four chemists under the supervision of Mr. Ward. The Company manufactures 100% of its products at its FDA registered facility in accordance with GMP standards.

The Company is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). As reported in its Form 8-K filed with the SEC on November 13, 2018, the Company recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. The Company’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

* These statements have not been evaluated by the Food and Drug Administration.

* This product is not intended to diagnose, treat, cure or prevent any disease.

Forward-Looking Statements

This communication contains statements of a forward-looking nature about NutraFuels, Inc. (the “Company”). These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

Selling cannabis or hemp on Times Square? Florida company makes marketing history

/in

Check out our news article on FloridaPolitics.com

While CBS still won’t run medical marijuana advertisements during the Super Bowl, a Florida company just ran the first-ever ads for cannabis-based products in Times Square.

NutraFuels, a nutraceutical manufacturing company with a line of hemp-derived CBD products under the brand NutraHempCBD (www.nutrahempcbd.com) was in the first digital billboard cannabis campaign in the famed intersection.

“This ad campaign was our way to celebrate the deregulation of hemp and create awareness of its health and wellness benefits,” said Edgar Ward, president and CEO of NutraFuels.

While companies with hemp and cannabis products in the past have tried to buy ad space in Times Square before, the marketing debuted concurrently with a change in the law.

Until this year, federal law technically classified all parts of the cannabis plant as marijuana, a scheduled narcotic. But the 2018 Farm Bill, as explained by the Billings Institute, differentiated hemp, a part of the plant containing less than 0.3 percent tetrahydrocannabinol. Better known as THC, that’s the stuff that gets people high.

“This campaign was our way of celebrating the Farm Bill and the deregulation of hemp,” said NutraFuels spokeswoman Chloe Sommers.

While the federal government long turned a blind eye to the sale of hemp and CBD oil, which can be sold in all 50 states, major media companies would not accept an advertisement for a product still technically prohibited by law.

It’s much the same reasoning that led CBS to reject an advertisement for Acreage Holdings, which sells medical marijuana, on the grounds the government still considers the sale of the product a crime.

But after the deregulation of hemp and CBD, Honeysuckle Magazine, a lifestyle magazine that regularly writes about the organic products, got approval to run a Times Square billboard campaign.

“It sounded interesting to me, so I jumped on the chance,” said Ronit Pinto, Honeysuckle owner. She offered space to many of advertisers working with her company, and many cannabis-related brands took part, including NutraFuels.

It turns out, the campaign marked the first time anyone sold cannabis-based products like hemp and CBD on a Times Square billboard.

“We started realizing what a great opportunity this involved for a lot of our brand partners, and just kept buying more time,” she said. “It became a huge thing.”

NutraFuels advertised its in-house CBD product NutraHempCBD. The ads provided tremendous exposure for the Coconut Beach-beached company, which employs about 12 people.

The Florida business remains one of the companies that’s continued to participate in the campaign as ad buys stretched into February.

The campaign still faces certain restrictions, Pinto said. There can’t be any pictures of the actual cannabis plant.

Advertisements also can’t show drug paraphernalia as the content must focus on those cannabis products legal under the new farm bill.

But the high-profile advertising could mark the first entry into mainstream marketing for a growing cannabis industry. Maybe the Super Bowl in 2020 will see such products promoted in commercial breaks.

“It’s the right thing to do,” Sommers said. “If you are doing the right thing and doing it by the rules, you should be able to market your product and be seen. CBS is buying into a stigma that’s actually flawed.”

“When it comes to cannabis, until the federal cannabis laws change like the hemp laws were, national media companies will be unlikely to accept their advertising,”  said NutraFuels spokesperson Chloe Sommers. “This positions CBD products well and it looks like it will only get better with time.

“When it comes to cannabis, until the federal cannabis laws change like the hemp laws were, national media companies will be unlikely to accept their advertising. This positions CBD products well and it looks like it will only get better with time.”

Fulfill Your Health Resolutions With NutraFuels NutraHempCBD CBD Lifestyle Kits, Nearly 50% Off

/in

Its a New year, and a new you! Check out NutraHempCBDs new 2019 healthy lifestyle starter kits. The Lifestyle Pack includes; NutraHempCBDs best-selling 600mg CBD tincture, the luxurious CBD Face Cream, a bundle of CBD Sleep Twists, and the popular Stress CBD Oral Spray all for $99.99. Originally priced at $188.75 this deal is almost 50% off.

The Lifestyle Pro Pack has its number one 900mg, the CBD Pain Balm, a bundle of CBD Stress Twists, and is completed with a convenient pocket-sized CBD Energy Spray for the discounted price of $129.99. The original market price for all these products together would be $233.75, this kit is nearly 50% off.

Also, back by popular demand is the NutraHempCBD 75% off discount for its 3-pack of Weight loss CBD oral sprays. The NutraHempCBD Weight Loss spray supports weight and appetite control through its formulation of CBD and Garcinia Cambogia(GC). GC has been shown to support healthy blood sugar control. The CBD and GC formulation can also support weight loss.

Use the recommended dose of 6 sprays 15 minutes before your meal and the CBD and Garcinia Cambogia will help as an appetite suppressant and support blood sugar (glucose) control.

Get healthy in 2019 by adding CBD to your routine. These all-in-one CBD lifestyle kits and the weight loss CBD oral spray bundle specials will help you toward a healthy 2019.

NutraFuels Inc. is a nutraceutical company with a line of CBD-infused products known by its in-house brand, NutraHempCBD. Using premium CBD hemp oil, its formulations are designed to promote overall health and wellness. NutraHempCBD products are intended for daily use with observed health benefits including anti-stress, anti-inflammation, calmness to sleep and stay asleep.

NutraFuels, Inc is a fully reporting company with a class of securities registered with the U.S. Securities & Exchange Commission (SEC). As reported in its Form 8-K filed with the SEC on November 13, 2018, NTFU recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFUs filings with the SEC can be viewed at www.sec.gov. NTFUs CBD products and information about the companys direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

Forward-Looking Statements

This communication contains statements of a forward-looking nature. These statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as may, will, except, anticipate, aim, estimate, intend, plan, believe, is/are likely to, future or other similar expressions. The Company has based these forward-looking statements largely on the Companys current expectations and projections about future events and financial trends that the Company believes may affect Companys financial condition, results of operations, business strategy, and financial needs. There is no assurance that Companys current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Companys actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Companys filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled Risk Factors, in the Companys Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Companys management to predict all risk factors, nor can the Company assess the impact of all factors on Companys business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

Contact:

NutraFuels, Inc.

6601 Lyons Road, Suite L-6
Coconut Creek, FL 33073

Telephone 888-509-8901
www.NutraFuels.com
www.ShopNutraHempCBD.com

Fulfill Your Health Resolutions With NutraFuels NutraHempCBD CBD Lifestyle Kits, Nearly 50% Off

NutraFuels Inc. (OTCQB:NTFU) Utilizes Nanotechnology for Its CBD-infused Products

/in

To read this press release on OTCMarkets.com visit:

NutraFuels Inc. (OTCQB:NTFU) Utilizes Nanotechnology for Its CBD-infused Products

Coconut Creek, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraFuels, Inc. (“NTFU” or the “Company”), Nutraceutical & CBD Manufacturer & Distributor, announces its use of Nanotechnology in its CBD-infused line of products distributed under its NutraHempCBD brand.

NTFU’s nanotechnology is designed to provide optimal absorption into the body of NTFU’s CBD-infused formulations. Nanotechnology refers to dealing with matter on a very small scale. Nanotechnology allows the smaller cannabinoid particles to be in their most bio-active form for fast absorption and high potency.

“We believe that our proprietary processing utilizing nanotechnology allows for us to create superior products with enhanced bioavailability,” said Edgar Ward, CEO, and Founder of NutraFuels Inc., “We believe that nanotechnology and our enhanced delivery system allows us to give our customers the most effective and efficient delivery system.”

According to Andrij Holian of the Center for Environmental Health Sciences Biomedical and Pharmaceutical Sciences, “Nanoparticles have become a significant interest as a drug delivery system due to their small size and large surface area.”

NutraFuels Inc., a publicly held company traded on the OTCQB under the ticker symbol NTFU, is a nutraceutical company with a line of CBD-infused products known by its in-house brand, NutraHempCBD. Using premium CBD hemp oil, its formulations are designed to promote overall health and wellness. NutraHempCBD products are intended for daily use with observed health benefits including anti-stress, anti-inflammation, calmness to sleep and stay asleep.

NutraHempCBD uses its specialty process to decrease the particle size and uses nano nanoemulsion in its products. For example, its Joint and Pain Balm aids in the alleviation pain with a silky and soothing formulation. Studies suggest that the key ingredient, CBD, may reduce inflammation while interacting with neurotransmitters. The CBD-infused Face Cream is made with Shea Butter and works to maintain elasticity of the delicate facial tissue. CBD studies have shown anti-inflammatory properties as well as a reduction in acne. For a full list of products including Nutrahemp CBD oral sprays, the day and nighttime formulas, and NutraPet oil visit its website.

NutraFuels, Inc is a fully reporting company with a class of securities registered with the U.S. Securities & Exchange Commission (“SEC”). As reported in its Form 8-K filed with the SEC on November 13, 2018, NTFU recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

Forward-Looking Statements
This communications contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,”, “intends”, “anticipate,” “aim,” “estimate,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. NutraFuels, Inc. (“NTFU” or the “Company”) has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy and financial needs. There is no assurance that Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

 

 

NutraFuels, Inc. (NTFU: OTC MARKETS) Brings Gifts of Wellness with its In-House Line of CBD Products, NutraHempCBD, and Announces Discounts for Its Holiday Debut

/in

To read this press release on OTCMarkets.com visit:

NutraFuels, Inc. (NTFU: OTC MARKETS) Brings Gifts of Wellness with its In-House Line of CBD Products, NutraHempCBD, and Announces Discounts for Its Holiday Debut

Coconut Creek, FL, Nov. 20, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraFuels (NTFU or “The Company”) is celebrating its first holiday season with its new Cannabidiol-infused (CBD) line of Health and Wellness products under the name NutraHempCBD.com with 25% off of all products on its website. Specializing in everything from moisturizing face creams to tasty tinctures, NutraHempCBD.com products come in a variety of CBD full-spectrum and isolate formulas using one of the most advanced delivery systems available to the nutraceutical industry.

The holiday CBD debut sale begins on Thanksgiving at midnight and will continue throughout the weekend until Cyber Monday at midnight. There’s no code needed to get the deep discounts and customers will also receive free shipping (within the US).

Give the gift of wellness this season with NutraHempCBD oral sprays which are designed to effectively and efficiently deliver the CBD and other nutrients into the body. To win the battle of the bulge this Thanksgiving Day, there are NutraHempCBD products to support multiple daily Health and Wellness uses including Weight Loss https://www.nutrahempcbd.com/store/2003/product/95. Also, NTFU’s CBD oral sprays come in formulas for Stress, https://www.nutrahempcbd.com/store/2003/product/91 Sleep, https://www.nutrahempcbd.com/store/2003/product/94 Pain & Joint, https://www.nutrahempcbd.com/store/2003/category/2432/product/93 and Energy & Focus. https://www.nutrahempcbd.com/store/2003/product/92 For your furry friend, there’s NutraPet, a tincture made for cats and dogs. https://www.nutrahempcbd.com/store/2003/product/90

NutraFuels Inc. is a fully reporting company with a class of securities registered with the U.S. Securities & Exchange Commission (“SEC”). As reported in its Form 8-K filed with the SEC on November 13, 2018, NTFU recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

Forward Looking Statements

This communication contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,”, “intends”, “anticipate,” “aim,” “estimate,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. NutraFuels, Inc. (“NTFU” or the “Company”) has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy and financial needs. There is no assurance that Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

NutraFuels Inc. (OTCQB: NTFU), CBD Nutraceutical Manufacturers, Announces New Product Line of Travel-Size CBD Products for Retailers and Consumers

/in

To read this press release on OTCMarkets.com visit:

NutraFuels Inc. (OTCQB: NTFU), CBD Nutraceutical Manufacturers, Announces New Product Line of Travel-Size CBD Products for Retailers and Consumers

COCONUT CREEK, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NTFU announced they will be introducing three new single-serve products as an addition to its line of Cannabidiol (CBD) infused nutraceuticals, NutraHempCBD. The CBD Drink Shots, CBD Twists, and Oral Sprays will come in a variety of flavors and formulations. All products are produced with NTFU’s high manufacturing standards and proprietary system formulations for optimal nutrient delivery.

NutraHempCBD Drink Shots will come in three formulations: Energy and Performance, Sleep and Restore, and simply CBD. The quick drink options for consumers will come in 1-ounce drink shots infused with 25mg CBD for a convenient single-serving of CBD.

The CBD Twists will come in five formulations for daily applications such as; Stress, Pain, Weight, Sleep, and Energy. The one-dose impulse buys come in 20mg CBD twists and come in ready-to-sell packaging.

The new CBD Oral Sprays also come in Stress, Pain, Weight, Sleep, and Energy formulations. These skinny 8 ml 10 serving pocket-size CBD sprays are water-based and contain 60mg of CBD.

“Each of our products helps to create a stable feeling of wellness,” said Ward, “and the daily applications are meant to support consumers all day and night with heightened focus, supportive energy, and calming sleep formulas.”

CBD infused products have gained the attention for smaller companies like NTFU and large well-established brands. Coca-Cola recently announced it is looking into CBD-infused drinks and companies such as New Age Beverages, makers of Coco Libre coconut water, are expanding the scope of offerings to include CBD.

NTFU’s mission is to provide the most efficient and effective nutrient delivery systems for CBD-infused products. NTFU’s new products aim to open the CBD market to a wider consumer base with a more affordable price point for single-dose items. These one-dose products will be available direct to the consumer, to retail, and wholesale outlets.

NutraFuels is a fully reporting company with a class of securities registered with the SEC. The Company’s filings can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

Forward Looking Statements

This communication contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy and financial needs. There is no assurance that Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.